Articles

Last January 3, the U.S. Food and Drug Administration (FDA) decided to get tough on transvaginal mesh manufacturers. After noting a five-fold increase in complications among women implanted with the polypropylene mesh to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), the FDA asked the mesh makers to […]

In a white paper about hernia mesh, analyst Winifred S. Hayes of Hayes Consulting helps one client figure out how to save money and be more efficient with their mesh purchases. The problem has been that in the case of hernia mesh, hospitals buy from a number of vendors and […]

A new Danish study in the journal, Calcified Tissue International, finds that a lower dose of osteoporosis drugs, also known as bisphosphonates, may actually represent a greater risk by about 50 percent of acute myocardial infarction, or clogging of the coronary vessels, when compared to a higher dose. Researchers from […]

Too often it seems that white collar crime pays. That may not be the case for executives of Johnson & Johnson in a couple of high-profile cases moving toward trial. Not only will Ethicon (a division of J & J) be forced to be deposed in the ongoing transvaginal mesh […]

The consumer advocacy group, Public Citizen, has filed a federal complaint against the U.S. Food and Drug Administration (FDA) to have the higher dose of the Alzheimer’s drug, Aricept, taken off the market because of the risk of fatal complications. The group made the first request 15 months ago and […]

U.S. News and World Report is revisiting a topic that needs to be revisited – the huge number of medical errors that harm and kill patients. The in-depth news report starts with a lesson presented to students at the University of Buffalo, New York, about an 88-year-old woman who was […]

In December, at the Joint meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the Food and Drug Administration, oral contraceptives containing drospirenone, approved since 2001, were discussed in detail. Drospirenone is a form of progestin, a synthetic hormone which is […]

Physicians from American University in Lebanon published a case report regarding Pradaxa (dabigatran etexilate) that was published in the July 28, 2012, edition of the Journal of Thrombosis and Thrombolysis.  In this article, the authors wrote about an 85 year old patient who developed shortness of breath, anemia, and white […]

Johnson & Johnson’s new CEO, Alyx Gorsky, will not be able to avoid having his deposition taken in preparation for the upcoming transvaginal mesh lawsuits pending before a New Jersey Superior Court. The ruling came down July 19, 2012, one day before a landmark ruling in another mesh case in […]

[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text] Thirteen individuals have sued the makers of Nexium and Prevacid in California state court alleging the drug maker failed to adequately warn doctors and consumers that the acid reflux drugs cause bone loss and osteoporosis. Nexium, manufactured by AstraZeneca, and Prevacid, made by Takeda, are associated with […]